We are live on
!
Find out more
BFG
Bleakley Financial Group Portfolio holdings
AUM
$6.39B
1-Year Est. Return
26.33%
This Fund
S&P 500
This Quarter
Est. Return
+5.7%
1 Year Est. Return
+26.33%
3 Year Est. Return
+77.54%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.2B
AUM Growth
+$209M
(+7%)
Cap. Flow
+$66.4M
Cap. Flow
% of AUM
2.07%
Top 10 Holdings %
Top 10 Hldgs %
28.66%
Holding
997
New
87
Increased
510
Reduced
305
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Mid-Cap ETF
VO
|
+$6.61M |
| 2 |
HCA Healthcare
HCA
|
+$6M |
| 3 |
Vanguard Large-Cap ETF
VV
|
+$5.92M |
| 4 |
Vanguard Total World Stock ETF
VT
|
+$4.48M |
| 5 |
Procter & Gamble
PG
|
+$3.69M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APLS
Apellis Pharmaceuticals
APLS
|
+$8.9M |
| 2 |
Agilent Technologies
A
|
+$6.86M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$6.58M |
| 4 |
Apple
AAPL
|
+$6.17M |
| 5 |
Abbott
ABT
|
+$5.81M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.85% |
| 2 | Healthcare | 10.44% |
| 3 | Financials | 5.01% |
| 4 | Consumer Discretionary | 4.57% |
| 5 | Communication Services | 3.76% |
Similar funds
EI
PCH
GT
EWM
BFS
EC
RIG
HI
Bleakley Financial Group's Q2 2023 Portfolio in Review
As of Q2 2023, Bleakley Financial Group held 997 positions worth $3.2B, up 7% from $3B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Bleakley Financial Group's Q2 2023 filing shows 87 new, 510 increased, 305 reduced and 71 closed positions. Its largest new stake was Monro: 54,860 shares worth $2.23M. The largest sale was Apellis Pharmaceuticals, an estimated $8.9M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
- Bleakley Financial Group's largest Q2 2023 buy was Monro: 54,860 shares worth $2.23M.
- Bleakley Financial Group added most to Vanguard Mid-Cap ETF in Q2 2023, an estimated $6.61M increase.
- Bleakley Financial Group's biggest Q2 2023 reduction was Apellis Pharmaceuticals, cutting an estimated $8.9M.
- Bleakley Financial Group fully exited ABB Ltd in Q2 2023, selling an estimated $3.61M.
- Bleakley Financial Group's ten largest holdings make up 29% of its $3.2B portfolio in Q2 2023.
- Bleakley Financial Group opened 87 new positions and closed 71 in Q2 2023.
- Bleakley Financial Group's portfolio value rose 7% quarter-over-quarter to $3.2B.
Based on Bleakley Financial Group's 13F filing for Q2 2023, filed 14 Aug 2023.